Globus Medical (GMED) Tops Q4 EPS by 9c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.39, $0.09 better than the analyst estimate of $0.30. Revenue for the quarter came in at $142.6 million versus the consensus estimate of $141.2 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AMC Entertainment prices $200M stock offering to redeem senior notes
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates